Despite a high debt load of $727.3M (D/E of 3.91), the company maintains a current ratio of 3.87 and cash of $246.7M, though cash has declined from $520.4M in 2024Q1, indicating a thinning liquidity cushion.
iRhythm Technologies, Inc. (IRTC) balance sheet — 13-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 |
|---|
| Total Current Assets | 730.21M | 702.76M | 645.82M | 230.81M | 288.77M | 305.52M | 377.82M | 172.79M | 106.48M | 119.58M | 118.61M | 32.83M | 15.53M | 11.74M |
| Cash & Short-Term Investments | 560.72M | 583.76M | 535.55M | 133.76M | 213.14M | 239.13M | 335.22M | 140.55M | 78.34M | 102.36M | 106.05M | 25.21M | 8.62M | 7.1M |
| Cash Only | 394.72M | 236.01M | 419.6M | 36.17M | 78.83M | 127.56M | 88.63M | 20.46M | 20.02M | 8.67M | 51.64M | 25.21M | 8.62M | 7.1M |
| Short-Term Investments | 166M | 347.75M | 115.96M | 97.59M | 134.31M | 111.57M | 246.59M | 120.09M | 58.32M | 93.69M | 54.41M | 0 | 0 | 0 |
| Accounts Receivable | 81.13M | 75.71M | 79.94M | 61.48M | 49.92M | 46.43M | 29.93M | 23.87M | 19.79M | 12.95M | 9.41M | 5.58M | 5.85M | 3.69M |
| Days Sales Outstanding | 34.4 | 36.98 | 49.3 | 45.55 | 44.34 | 52.5 | 41.2 | 40.6 | 49.05 | 47.69 | 53.58 | 56.33 | 98.23 | 87.62 |
| Inventory | 23.22M | 21.63M | 14.04M | 13.97M | 15.15M | 10.27M | 5.31M | 4.04M | 2.06M | 1.68M | 1.39M | 1.15M | 818K | 747K |
| Days Inventory Outstanding | 35.11 | 35.91 | 27.8 | 31.7 | 42.78 | 34.3 | 27.59 | 28.07 | 19.4 | 21.78 | 24.29 | 28.43 | 28.19 | 30.82 |
| Other Current Assets | 10M | 21.66M | 16.29M | 21.59M | 10.55M | 9.69M | 7.36M | 4.34M | 4.1M | 2.58M | 91K | 91K | 0 | 0 |
| Total Non-Current Assets | 361.23M | 317.28M | 285.63M | 202.33M | 159.45M | 157.44M | 133.91M | 133.42M | 13.23M | 13.54M | 19.55M | 5.04M | 2.98M | 1.52M |
| Property, Plant & Equipment | 214.61M | 193.43M | 172.66M | 153.43M | 136.34M | 140.53M | 118.96M | 116.59M | 9.16M | 6.22M | 4.65M | 2.04M | 751K | 403K |
| Fixed Asset Turnover | 4.22x | 3.86x | 3.43x | 3.21x | 3.01x | 2.30x | 2.23x | 1.84x | 16.08x | 15.93x | 13.77x | 17.75x | 28.96x | 38.13x |
| Goodwill | 862K | 862K | 862K | 862K | 862K | 862K | 862K | 862K | 862K | 862K | 862K | 862K | 862K | 862K |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 290.97M | 69.91M | 61.9M | 3M | 0 | 0 | 0 | 8.03M | 0 | 2.99M | 10.98M | 0 | 0 | 0 |
| Other Non-Current Assets | 71.25M | 53.08M | 50.21M | 45.04M | 22.25M | 16.05M | 14.09M | 7.94M | 3.21M | 3.46M | 3.05M | 2.15M | 1.36M | 255K |
| Total Assets | 1.09B | 1.02B | 931.45M | 433.14M | 448.22M | 462.97M | 511.74M | 306.21M | 119.71M | 133.12M | 138.16M | 37.87M | 18.51M | 13.26M |
| Asset Turnover | 0.81x | 0.73x | 0.64x | 1.14x | 0.92x | 0.70x | 0.52x | 0.70x | 1.23x | 0.74x | 0.46x | 0.95x | 1.18x | 1.16x |
| Asset Growth % | 41.27% | 9.51% | 115.04% | -3.36% | -3.18% | -9.53% | 67.12% | 155.79% | -10.08% | -3.64% | 264.8% | 104.61% | 39.55% | - |
| Total Current Liabilities | 204.73M | 151.89M | 110.92M | 107.37M | 89.1M | 87.85M | 65.67M | 52.07M | 30.24M | 20.92M | 13.21M | 8.78M | 4.86M | 4.26M |
| Accounts Payable | 15.39M | 2.26M | 7.22M | 5.54M | 7.52M | 10.51M | 4.37M | 8.24M | 2.28M | 2.4M | 2.1M | 1.46M | 1.2M | 494K |
| Days Payables Outstanding | 16.8 | 3.74 | 14.3 | 12.58 | 21.22 | 35.11 | 22.67 | 57.32 | 21.49 | 31 | 36.76 | 36.23 | 41.25 | 20.38 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 11.67M | 11.67M | 1.94M | 0 | 1.49M | 0 | 0 | 0 | 1.63M |
| Deferred Revenue (Current) | 17.13M | 4.2M | 2.93M | 3.31M | 3.05M | 3.05M | 930K | 1.25M | 1.24M | 1.24M | 947K | 506K | 0 | 0 |
| Other Current Liabilities | 0 | 662K | 585K | 1.04M | 18.7M | 1M | 13.96M | 9.75M | 5.81M | 1.38M | 257K | 0 | 421K | 28K |
| Current Ratio | 3.57x | 4.63x | 5.82x | 2.15x | 3.24x | 3.48x | 5.75x | 3.32x | 3.52x | 5.72x | 8.98x | 3.74x | 3.20x | 2.75x |
| Quick Ratio | 3.45x | 4.48x | 5.70x | 2.02x | 3.07x | 3.36x | 5.67x | 3.24x | 3.45x | 5.64x | 8.87x | 3.61x | 3.03x | 2.58x |
| Cash Conversion Cycle | 52.71 | 69.15 | 62.8 | 64.68 | 65.9 | 51.69 | 46.12 | 11.35 | 46.96 | 38.48 | 41.12 | 48.53 | 85.17 | 98.06 |
| Total Non-Current Liabilities | 709.6M | 715.41M | 729.62M | 115.68M | 119.31M | 95.6M | 104.46M | 118.74M | 35.05M | 32.65M | 32.38M | 130.72M | 6.38M | 4.4M |
| Long-Term Debt | 651.86M | 649.5M | 646.44M | 34.95M | 34.94M | 9.69M | 21.34M | 32.99M | 34.9M | 32.49M | 32.23M | 30.55M | 6.25M | 4.21M |
| Capital Lease Obligations | 243.36M | 64.99M | 74.6M | 79.72M | 83.07M | 85.21M | 81.29M | 85.75M | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 908K | 908K | 8.58M | 1.01M | 1.31M | 697K | 1.83M | 0 | 153K | 161K | 152K | 100.17M | 130K | 190K |
| Total Liabilities | 914.34M | 867.3M | 840.54M | 223.05M | 208.41M | 183.45M | 170.13M | 170.8M | 65.29M | 53.57M | 45.59M | 139.5M | 11.24M | 8.66M |
| Total Debt | 725.73M | 731.18M | 736.91M | 129.82M | 131.04M | 117.71M | 122.47M | 128.59M | 34.9M | 33.98M | 32.23M | 30.55M | 6.25M | 5.84M |
| Net Debt | 331.02M | 495.17M | 317.31M | 93.65M | 52.21M | -9.85M | 33.84M | 108.13M | 14.88M | 25.31M | -19.42M | 5.34M | -2.36M | -1.26M |
| Debt / Equity | 4.10x | 4.79x | 8.11x | 0.62x | 0.55x | 0.42x | 0.36x | 0.95x | 0.64x | 0.43x | 0.35x | - | 0.86x | 1.27x |
| Debt / EBITDA | -56.54x | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | -25.79x | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -1.85x | -2.31x | -7.79x | -32.60x | -27.01x | -85.39x | -27.70x | -32.17x | -15.16x | -7.78x | -5.44x | -20.53x | -19.45x | - |
| Total Equity | 177.11M | 152.75M | 90.91M | 210.1M | 239.81M | 279.51M | 341.61M | 135.41M | 54.42M | 79.55M | 92.56M | -101.62M | 7.26M | 4.6M |
| Equity Growth % | 278.75% | 68.02% | -56.73% | -12.39% | -14.2% | -18.18% | 152.28% | 148.81% | -31.59% | -14.05% | 191.08% | -1499.01% | 57.91% | - |
| Book Value per Share | 5.35 | 4.77 | 2.91 | 6.88 | 8.02 | 9.53 | 12.31 | 5.36 | 2.28 | 3.52 | 17.51 | -6.88 | 0.49 | 3.62 |
| Total Shareholders' Equity | 177.11M | 152.75M | 90.91M | 210.1M | 239.81M | 279.51M | 341.61M | 135.41M | 54.42M | 79.55M | 92.56M | -101.62M | 7.26M | 4.6M |
| Common Stock | 33K | 32K | 31K | 31K | 28K | 27K | 27K | 25K | 23K | 23K | 22K | 1K | 8K | 8K |
| Retained Earnings | -847.61M | -803.45M | -758.89M | -645.61M | -522.2M | -406.05M | -304.68M | -260.39M | -203.51M | -156.59M | -127.17M | -106.27M | -83.47M | -67.64M |
| Treasury Stock | -25M | -25M | -25M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.64M | 0 | 0 |
| Accumulated OCI | -216K | 403K | 165K | -112K | -396K | -61K | 11K | 82K | -41K | -65K | -9K | -1.08M | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying IRTC stock.
As of 2025, iRhythm Technologies, Inc. (IRTC) had total assets of $1.02B including $702.8M in current assets.
iRhythm Technologies, Inc. (IRTC) carries total debt of $731.2M, offset by $583.8M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
iRhythm Technologies, Inc. (IRTC) has total shareholders' equity (book value) of $152.7M ($4.77 book value per share). Book value represents the net worth of the company belonging to common stock holders.
iRhythm Technologies, Inc. (IRTC) reported a current ratio of 4.63x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Reimbursement and regulatory overhang
Metrics are mathematically derived from official filings.
Equity Erosion Amid Revenue Growth
Despite 26% revenue growth, IRTC's equity fell from $90.3M in 2024Q1 to $186.0M in 2026Q2, but total liabilities rose 10.7%, indicating balance sheet strain, per reported financials.
The equity base has expanded from $90.3M to $186.0M over the period, but this is largely due to capital raises and retained losses, not organic profitability. Total liabilities increased from $819.5M to $906.9M, with debt remaining elevated near $727M, suggesting the company is funding growth through leverage. The trajectory implies that while revenue accelerates, the balance sheet is not yet self-sustaining, and investors should monitor whether equity growth can outpace liability accumulation.
Leverage Persists Despite Cash Buffer
IRTC's debt-to-equity ratio improved from 8.16 in 2024Q1 to 3.91 in 2026Q2, but total debt remains high at $727.3M, with cash of $246.7M, indicating a strategic reliance on debt financing, as per SEC filings.
The D/E ratio has halved, but this is primarily due to equity growth from capital raises, not debt reduction. Total debt has remained remarkably stable around $727-737M across ten quarters, suggesting the company is not aggressively deleveraging. With cash at $246.7M, the net debt position is approximately $480.6M, which appears manageable given the improving operating cash flow, but the fixed interest burden could strain margins if revenue growth stalls.
Asset Mix Shifts Toward Tangibles
PPE net increased 27.3% from $160.3M in 2024Q1 to $204.1M in 2026Q2, while goodwill remains minimal at $862K, indicating an asset-light model with growing investment in physical infrastructure, based on reported figures.
The increase in PPE suggests investment in manufacturing capacity or clinical operations, which aligns with the company's scaling efforts. Goodwill is negligible, implying that past acquisitions have not created significant intangible risk. The asset mix remains heavily weighted toward current assets, with a current ratio of 3.87, but the growing PPE base may signal a shift toward a more capital-intensive model, which could pressure future cash flows if not matched by revenue growth.
Retained Losses Mask Equity Quality
Accumulated deficit deepened to -$817.8M in 2026Q2 from -$691.3M in 2024Q1, yet equity rose to $186.0M, implying equity quality is driven by external capital, not retained earnings, as reported in financial statements.
The retained earnings deficit has grown by $126.5M over the period, reflecting cumulative losses, but equity has increased due to capital infusions. This suggests that the equity base is not organically generated, and the company remains dependent on external financing to support its balance sheet. Investors should monitor whether the narrowing operating losses can eventually reverse the retained earnings trend, which would signal a more sustainable equity structure.
Liquidity Buffer Thins as Cash Declines
Cash fell from $520.4M in 2024Q1 to $246.7M in 2026Q2, while the current ratio dropped from 7.10 to 3.87, indicating a shrinking liquidity cushion despite still-adequate coverage, per quarterly disclosures.
The cash balance has more than halved, reflecting significant cash burn in operations and investments, though operating cash flow turned positive in recent quarters. The current ratio remains above 3, providing a buffer, but the trend is concerning. With cash runway estimated at roughly 12 months based on current burn, the company may need to raise additional capital or achieve sustained profitability to avoid liquidity strain.
Debt Maturity and Refinancing Risk
Total debt of $727.3M with a D/E of 3.91 appears manageable, but the stability of debt levels over ten quarters suggests potential refinancing needs, which could be costly in a high-rate environment, as per reported balance sheets.
The debt has remained consistently around $730M, indicating that the company may have a term loan or convertible notes that are not being amortized. If this debt matures in the near term, refinancing at current interest rates could increase interest expense and pressure cash flows. Additionally, the company's lack of GAAP profitability may limit its access to favorable debt terms, making equity issuance a more likely path, which could dilute shareholders.